Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer (DISRUPT)

This study has been completed.
Information provided by (Responsible Party):
Sanofi Identifier:
First received: December 14, 2010
Last updated: October 29, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)